124 related articles for article (PubMed ID: 25720804)
21. New compounds hybrids 1h-1,2,3-triazole-quinoline against Plasmodium falciparum.
Boechat N; Ferreira Mde L; Pinheiro LC; Jesus AM; Leite MM; Júnior CC; Aguiar AC; de Andrade IM; Krettli AU
Chem Biol Drug Des; 2014 Sep; 84(3):325-32. PubMed ID: 24803084
[TBL] [Abstract][Full Text] [Related]
22. Net charge tuning modulates the antiplasmodial and anticancer properties of peptides derived from scorpion venom.
Pedron CN; Silva AF; Torres MT; Oliveira CS; Andrade GP; Cerchiaro G; Pinhal MAS; de la Fuente-Nunez C; Oliveira Junior VX
J Pept Sci; 2021 Apr; 27(4):e3296. PubMed ID: 33442881
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of 3H-Angiotensin II binding to zona glomerulosa cells by several analogs.
Gurchinoff S; Khairallah PA
Arch Int Pharmacodyn Ther; 1977 Jul; 228(1):15-22. PubMed ID: 562643
[TBL] [Abstract][Full Text] [Related]
24. Protein farnesyltransferase inhibitors exhibit potent antimalarial activity.
Nallan L; Bauer KD; Bendale P; Rivas K; Yokoyama K; Hornéy CP; Pendyala PR; Floyd D; Lombardo LJ; Williams DK; Hamilton A; Sebti S; Windsor WT; Weber PC; Buckner FS; Chakrabarti D; Gelb MH; Van Voorhis WC
J Med Chem; 2005 Jun; 48(11):3704-13. PubMed ID: 15916422
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and antimalarial activity of hydroxyethylpiperazine derivatives.
Cunico W; Gomes CR; Moreth M; Manhanini DP; Figueiredo IH; Penido C; Henriques MG; Varotti FP; Krettli AU
Eur J Med Chem; 2009 Mar; 44(3):1363-8. PubMed ID: 18514971
[TBL] [Abstract][Full Text] [Related]
26. Aryl piperazine and pyrrolidine as antimalarial agents. Synthesis and investigation of structure-activity relationships.
Mendoza A; Pérez-Silanes S; Quiliano M; Pabón A; Galiano S; González G; Garavito G; Zimic M; Vaisberg A; Aldana I; Monge A; Deharo E
Exp Parasitol; 2011 Jun; 128(2):97-103. PubMed ID: 21354139
[TBL] [Abstract][Full Text] [Related]
27. Chemotherapy of malaria and the host-parasite interaction.
Peters W
Indian J Malariol; 1984 Jun; 21(1):7-16. PubMed ID: 6399262
[No Abstract] [Full Text] [Related]
28. The anti-malarial activity of bivalent imidazolium salts.
Vlahakis JZ; Mitu S; Roman G; Patricia Rodriguez E; Crandall IE; Szarek WA
Bioorg Med Chem; 2011 Nov; 19(21):6525-42. PubMed ID: 21944972
[TBL] [Abstract][Full Text] [Related]
29. Aza vinyl sulfones: synthesis and evaluation as antiplasmodial agents.
Glória PM; Gut J; Gonçalves LM; Rosenthal PJ; Moreira R; Santos MM
Bioorg Med Chem; 2011 Dec; 19(24):7635-42. PubMed ID: 22071522
[TBL] [Abstract][Full Text] [Related]
30. Isolation of a substance from the mosquito that activates Plasmodium fertilization.
Garcia GE; Wirtz RA; Rosenberg R
Mol Biochem Parasitol; 1997 Sep; 88(1-2):127-35. PubMed ID: 9274874
[TBL] [Abstract][Full Text] [Related]
31. Proteomic analysis of Plasmodium falciparum schizonts reveals heparin-binding merozoite proteins.
Zhang Y; Jiang N; Lu H; Hou N; Piao X; Cai P; Yin J; Wahlgren M; Chen Q
J Proteome Res; 2013 May; 12(5):2185-93. PubMed ID: 23566259
[TBL] [Abstract][Full Text] [Related]
32. Hits, leads and drugs against malaria through diversity-oriented synthesis.
Dandapani S; Comer E; Duvall JR; Munoz B
Future Med Chem; 2012 Dec; 4(18):2279-94. PubMed ID: 23234551
[TBL] [Abstract][Full Text] [Related]
33. The A/T-specific DNA alkylating agent adozelesin inhibits Plasmodium falciparum growth in vitro and protects mice against Plasmodium chabaudi adami infection.
Yanow SK; Purcell LA; Spithill TW
Mol Biochem Parasitol; 2006 Jul; 148(1):52-9. PubMed ID: 16597469
[TBL] [Abstract][Full Text] [Related]
34. Rosetting and autoagglutination in Plasmodium falciparum.
Fernandez V; Wahlgren M
Chem Immunol; 2002; 80():163-87. PubMed ID: 12058638
[No Abstract] [Full Text] [Related]
35. Synthesis and structure-activity relationships of 4-pyridones as potential antimalarials.
Yeates CL; Batchelor JF; Capon EC; Cheesman NJ; Fry M; Hudson AT; Pudney M; Trimming H; Woolven J; Bueno JM; Chicharro J; Fernández E; Fiandor JM; Gargallo-Viola D; Gómez de las Heras F; Herreros E; León ML
J Med Chem; 2008 May; 51(9):2845-52. PubMed ID: 18396855
[TBL] [Abstract][Full Text] [Related]
36. Identification of a new chemical class of antimalarials.
Brunner R; Aissaoui H; Boss C; Bozdech Z; Brun R; Corminboeuf O; Delahaye S; Fischli C; Heidmann B; Kaiser M; Kamber J; Meyer S; Papastogiannidis P; Siegrist R; Voss T; Welford R; Wittlin S; Binkert C
J Infect Dis; 2012 Sep; 206(5):735-43. PubMed ID: 22732921
[TBL] [Abstract][Full Text] [Related]
37. Triterpenoids as inhibitors of erythrocytic and liver stages of Plasmodium infections.
Ramalhete C; da Cruz FP; Lopes D; Mulhovo S; Rosário VE; Prudêncio M; Ferreira MJ
Bioorg Med Chem; 2011 Dec; 19(24):7474-81. PubMed ID: 22071523
[TBL] [Abstract][Full Text] [Related]
38. Effects of dipyridamole on Plasmodium falciparum-infected erythrocytes.
Akaki M; Nakano Y; Ito Y; Nagayasu E; Aikawa M
Parasitol Res; 2002 Dec; 88(12):1044-50. PubMed ID: 12444453
[TBL] [Abstract][Full Text] [Related]
39. Antimalarial activities of peptide antibiotics isolated from fungi.
Nagaraj G; Uma MV; Shivayogi MS; Balaram H
Antimicrob Agents Chemother; 2001 Jan; 45(1):145-9. PubMed ID: 11120957
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of gallinamide A analogues as potent falcipain inhibitors and antimalarials.
Conroy T; Guo JT; Elias N; Cergol KM; Gut J; Legac J; Khatoon L; Liu Y; McGowan S; Rosenthal PJ; Hunt NH; Payne RJ
J Med Chem; 2014 Dec; 57(24):10557-63. PubMed ID: 25412465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
